ASX-Dividend-Report-Banner

Clarivate Repeats Success in Nobel Prize Predictions with Eight New Winners Identified by Citation Laureates Program

October 15, 2024 06:00 PM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Clarivate Repeats Success in Nobel Prize Predictions with Eight New Winners Identified by Citation Laureates Program
Image source: Kalkine Media

83 Citation Laureates named by the Institute for Scientific Information have received a Nobel Prize since 2002

LONDON, Oct. 15, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the success of its annual Citation Laureates™ program, following the accurate forecast of eight Nobel Prize 2024 recipients.

Powered by trusted, high-quality data from the Web of Science Core Collection™ citation index, the Citation Laureates program combines rigorous citation analysis with expert qualitative insights to pinpoint researchers with exceptional citation records who have the potential to receive Nobel honors. This ability to forecast Nobel success – whether years in advance or just months before the official announcements – underscores the reliability and value of this data-driven approach.

Since 2002, the Institute for Scientific Information (ISI)™ at Clarivate has identified 441 researchers as Citation Laureates, with 83 later receiving a Nobel Prize. It has successfully forecast recipients every year since 2007.

David Baker, Demis Hassabis and John M. Jumper were named as Citation Laureates this year, just weeks before their Nobel in Chemistry. Physiology or Medicine Nobelists Victor Ambros and Gary Ruvkun were first recognized as Citation Laureates 16 years ago, in 2008. The prize in Economic Sciences, awarded to Daron Acemoglu, Simon Johnson and James A. Robinson was forecast in 2022.

David Pendlebury, Head of Research Analysis, ISI, Clarivate, said: "The Nobel committees' choices for both Physics and Chemistry can only be described as bold. The acknowledgment of the transformational role of AI in research in the two categories, back-to-back, is unprecedented. In Chemistry, we quickly saw something extremely unusual with the key AlphaFold paper from Hassabis and Jumper of DeepMind. Published just three years ago, in 2021, it swiftly amassed more than 16,000 citations in the Web of Science Core Collection. This phenomenally high number is statistically unusual and was achieved so quickly, we could not ignore its influence."

Dr. Nandita Quaderi, Senior Vice President & Editor-in-Chief, Web of Science, Clarivate, said: "Accurately predicting Nobel laureates is challenging. Our ISI analysts have combined their deep bibliometric expertise with more recent AI approaches to develop a proprietary methodology to identify researchers 'of Nobel class'. These individuals are responsible for producing the research that has the greatest societal impact and will help shape the future by solving the world's most pressing and complex challenges."

The eight Citation Laureates named as Nobel laureates in 2024 are:

Victor Ambros and Gary Ruvkun: Nobel Prize in Physiology or Medicine for their discovery of microRNA and its role in post-transcriptional gene regulation, named Citation Laureates in 2008. Ambros and Ruvkun's pioneering research on microRNAs dates back to 1993, and Ambros's key paper is cited nearly 10,000 times – an occurrence so rare that only 500 publications out of 61 million we have indexed since 1970 are cited at this level. The field they helped establish has expanded dramatically from a handful of papers 20 years ago to around 16,000 per year in 2020.

David Baker, Demis Hassabis and John M. Jumper: Nobel Prize in Chemistry for their research into protein structure prediction and computational protein design respectively, identified by ISI In September 2024. Hassabis and Jumper's 2021 paper has already received more than 16,000 citations – a remarkable number that reflects the revolutionary impact of this work.

Daron Acemoglu, Simon Johnson and James A. Robinson: The Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel for studies of how institutions are formed and affect prosperity, named Citation Laureates in 2022. The ISI identified all three using publication and citation analysis – their co-authored 2001 paper has received more than 5,000 citations, which ranks it among the top 10 papers in economics indexed in the Web of Science since 2000.

Notes to editors:

  • Analysts at the ISI name Citation Laureates aligned to the four Nobel categories of Physiology or Medicine, Physics, Chemistry and Economic Sciences. In 2011, 2013 and 2021, the ISI accurately predicted Nobel laureates in all four fields of research.
  • Since 2007, the ISI at Clarivate has successfully forecast researchers who have been the recipients of Nobel Prizes every single year.
  • Learn more about the Hall of Citation Laureates and watch our video interviews with David Baker, John M. Jumper, Daron Acemoglu and James A. Robison.
  • David Pendlebury, Head of Research Analysis at the Institute for Scientific Information at Clarivate is available for interviews.

About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

Media contact:
Rebecca Krahenbuhl, Senior Manager, External Communications
[email protected]


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.